Neurocrine Biosciences, Inc. (NBIX): Price and Financial Metrics

NBIX POWR Grades

• Quality is the dimension where NBIX ranks best; there it ranks ahead of 85.61% of US stocks.
• The strongest trend for NBIX is in Stability, which has been heading down over the past 179 days.
• NBIX's current lowest rank is in the Momentum metric (where it is better than 12.28% of US stocks).

NBIX Stock Summary

• NBIX's current price/earnings ratio is 98.71, which is higher than 93.33% of US stocks with positive earnings.
• The price/operating cash flow metric for Neurocrine Biosciences Inc is higher than 84.07% of stocks in our set with a positive cash flow.
• With a price/sales ratio of 7.8, Neurocrine Biosciences Inc has a higher such ratio than 81.42% of stocks in our set.
• Stocks that are quantitatively similar to NBIX, based on their financial statements, market capitalization, and price volatility, are DLB, CHKP, RVNC, AXTI, and MITK.
• NBIX's SEC filings can be seen here. And to visit Neurocrine Biosciences Inc's official web site, go to www.neurocrine.com.

NBIX Valuation Summary

• NBIX's price/sales ratio is 8.7; this is 128.95% higher than that of the median Healthcare stock.
• Over the past 243 months, NBIX's EV/EBIT ratio has gone up 115.2.
• NBIX's price/sales ratio has moved down 53.7 over the prior 243 months.

Below are key valuation metrics over time for NBIX.

NBIX Growth Metrics

The 5 year price growth rate now stands at 142.63%.
• Its year over year price growth rate is now at -11.48%.
• Its year over year cash and equivalents growth rate is now at 87.07%.

Over the past 52 months, NBIX's revenue has gone up $1,066,391,000.

The table below shows NBIX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1,133.5	256.5	89.6
2021-09-30	1,069.4	341.2	444.8
2021-06-30	1,031.9	261.9	364.7
2021-03-31	1,045.4	277.6	402
2020-12-31	1,045.9	228.5	407.3
2020-09-30	1,042.01	242.153	93.4

NBIX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NBIX has a Quality Grade of B, ranking ahead of 78.08% of graded US stocks.
• NBIX's asset turnover comes in at 0.566 -- ranking 66th of 682 Pharmaceutical Products stocks.
• LGND, MNKD, and MRK are the stocks whose asset turnover ratios are most correlated with NBIX.

The table below shows NBIX's key quality metrics over time.